Compounding Labelling White Paper 
Pharmaceutical Technology
JUNE 26, 2025
Free Whitepaper How value-based care is reshaping the life sciences This free white paper examines the benefits of value-based care (VBC) and how this translates into the wider life-sciences landscape. AI models can predict molecular interactions and assist in designing novel compounds tailored to specific therapeutic goals.
Pharmaceutical Technology
AUGUST 13, 2025
GlobalData pharma analyst Vinie Varkey says: “Brinsupri represents the first on-label non-antibiotic, anti-inflammatory treatment option that offers a more targeted action and possibly shift away from use of antibiotics in this disease space.” However, until now, there has been no therapy specifically approved for the condition.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 30, 2025
The planned 160,000ft² facility will focus on aseptic production and includes areas for material preparation and compounding. How will RFK Jr’s American dream for vaccines play out? Find out more Ground preparation work for the new site commenced in April after obtaining the building permit.
Pharmaceutical Technology
JULY 8, 2025
The pulmonary arterial hypertension (PAH) market is forecast to grow at a compound annual growth rate (CAGR) of 2.0% Symptoms such as fatigue, breathlessness, and chest pain are frequently misattributed to more common conditions, delaying intervention and compounding disease burden. Credit: Green Apple via Shutterstock.
Pharmaceutical Technology
JULY 10, 2025
Ross Law July 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The global oncology market is set to grow at a compound annual growth rate (CAGR) of 24.5%. Image credit: CI Photos / Shutterstock. Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
Pharmaceutical Technology
AUGUST 14, 2025
billion in 2030, representing a robust compound annual growth rate of 19.4%, according to GlobalData. The eosinophilic oesophagitis (EoE) market in the US is forecast to grow from $202 million in 2020 to $1.19
epicur
FEBRUARY 23, 2023
Traditional 503A compounding pharmacies and 503B outsourcing manufacturers both serve as important partners for veterinary practices, providing patient-specific prescriptions and manufacturing bulk drugs for in-practice use and dispensing when allowed by state regulations. In many cases, those variances have led to compounding tragedies.
Expert insights. Personalized for you.
Let's personalize your content